GB

George Bandarian

General Partner & CEO at Untapped

Los Angeles Metropolitan Area

Overview 

George Bandarian is the General Partner at Untapped Ventures, driving AI innovation and making significant investments in companies like Finnt. He has a Bachelor of Science in Business Administration from USC Marshall School of Business and has successfully invested in various startups, contributing to the growth of the AI and technology sectors. Bandarian's career highlights include founding Untapped Ventures and investing in a range of companies, showcasing his expertise in AI, business planning, and strategic investments. His role involves leading investments in Series A and Seed stages within sectors such as Space, SaaS, Enterprise, and the Future of Work, primarily focusing on the Los Angeles/Southern California region.

Work Experience 

  • Founder, General Partner & CEO

    2020 - Current

    Untapped Ventures is an Early-Stage Venture Fund focused on AI that Uplifts Humanity.

  • Investor

    2024

  • Investor

    2024

XAI is an AI company that develops a platform to accelerate human scientific discovery.

Raised $12,384,679,312.00 from Valor Equity Partners, Sequoia Capital, Andreessen Horowitz, Qatar Investment Authority and CoreNest Capital.

  • Investor

    2024

You.com is an AI chatbot and search engine that uses LLM to deliver personalized responses to queries with human-like replies.

Raised $95,000,000.00 from Georgian, SBVA, Day One Ventures, Alumni Ventures, DuckDuckGo, NVIDIA and Salesforce Ventures.

  • Investor

    2024

Optios is a neuroperformance company that uses proprietary, state-of-the-art neurotechnology to unlock the brain’s potential.

  • Investor

    2024

Climax Foods creates plant-based ingredients and products using data-driven technology and culinary expertise.

Raised $26,600,000.00 from Bel Group, Schox Venture Capital, Valhalla Ventures, Canaccord Genuity Group, S2G Ventures, Hummingbird Ventures, Carrot Capital, At One Ventures, Index Ventures and Artis Ventures (AV).

  • Investor

    2024

  • Investor

    2023

Radicle Science is a health tech company that offers an accelerated, non-FDA route to drug validation.

Raised $5,999,716.00 from Everywhere Ventures, Ensemble, Chang Corporation, Santa Barbara Angel Alliance, Wayne Chang, Social Impact Capital and Jeff Seibert.

  • Investor

    2023

Synapbox is a B2B platform that transforms raw consumer data into standardized performance metrics and actionable insights.

Raised $550,000.00 from Team Ignite Ventures and Alchemist Accelerator.

  • Investor

    2023

    Acquired by Veradigm

ScienceIO develops a biomedical language platform to transform complex medical text into usable data and actionable insights.

Raised $8,000,000.00 from Sinai Capital Partners, Highbury Group, Buckley Ventures, Banana Capital, Swell Partners, Dorm Room Fund, Jeff Silverstein, Quiet Capital, Josh Buckley and Neal Khosla.

Articles About George

Relevant Websites